ENGLEWOOD, Colo., May 4, 2023 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the “Selling Stockholder”), has determined not to pursue the public offering of 2,000,000 shares of the Company’s common stock that was…
Related Articles
News
Denver Business Journal to host inaugural Women’s Health Summit
February 27, 2025
UCBN
News, Syndication
Comments Off on Denver Business Journal to host inaugural Women’s Health Summit
Highlights include a fireside chat with former Peloton instructor Kendall Toole. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
PharmaJet Announces Implementation Study Results: Increased Coverage, Cost Savings, and Preference for Routine Polio Immunization with Tropis® ID Needle-free Delivery
October 24, 2024
UCBN
News, Syndication
Comments Off on PharmaJet Announces Implementation Study Results: Increased Coverage, Cost Savings, and Preference for Routine Polio Immunization with Tropis® ID Needle-free Delivery
GOLDEN, Colo.–(BUSINESS WIRE)–Routine polio immunization implementation study in Nigeria shows increased coverage, cost savings and preference for PharmaJet Tropis ID delivery. Click here to view original post Click Here to Publish/Feature Your Company or Product […]
News
Direct RNA Sequencing Supports Novel Discoveries in RNA Biology
November 1, 2024
UCBN
News, Syndication
Comments Off on Direct RNA Sequencing Supports Novel Discoveries in RNA Biology
Years of experiments and databases filled with RNA-seq results belie the simple reality that, until fairly recently, it was impossible to analyze RNA directly. The RNA-seq studies performed with conventional sequencing platforms are based entirely […]
